CTOs on the Move

BridgeHealth

www.bridgehealth.com

 
BridgeHealth connects people with the nation`s best surgical care for a better experience, better outcomes, and better value. We offer a value-based approach to surgical care for self-insured plan sponsors and their members, saving them an average of 30% to 50% on procedures compared with PPO rates. BridgeHealth`s nationwide Centers of Excellence focus on quality outcomes and provide pre-negotiated bundled case rates for a broad scope of surgical procedures, including musculoskeletal, neurological, general surgery, cardiac, bariatric, and women`s health. BridgeHealth contracts with hospital providers who rank in the top quartile for their clinical specialty, based on outcomes and other objective ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Kris Jamsa
Chief Technology Officer Profile

Funding

BridgeHealth raised $40M on 10/22/2020

Similar Companies

Hormone Treatment Center

Hormone Treatment Center is a Bellaire, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Austin Weston Center

Austin Weston Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Austin Weston Center is based in Reston, VA. You can find more information on Austin Weston Center at www.austin-weston.com

Dogwood Forest Of Alpharetta

Dogwood Forest Of Alpharetta is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sterling Life Sciences

Sterling Life Sciences is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nkarta Therapeutics

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.